English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Radiol Bras. 2015 Jan/Fev;48(1):VII In the last 25 years we could witness the developments in the diagnosis, management and follow-up of prostate cancer, from open (large wound) surgeries to minimally invasive procedures and active surveillance. From the freehand transperineal biopsy technique to the current transrectal ultrasonography-guided biopsy protocols, the malignancy prevalence has increased from about 20% to more than 50%, as demonstrated by the prospective study published in the present issue of Radiologia Brasileira, developed by researchers of Hospital de Santarem, in Portugal, where 155 patients were submitted to prostate biopsy without the knowledge about the prostate-specific antigen (PSA) values or results from previous sonographic studies. In the mentioned study, Lopes et al. collected 10 specimens as recommended by the European Association of Urology Guidelines on Prostate Cancer, besides an additional specimen in cases where a nodule was considered suspicious. The reported malignancy prevalence was 53%, with 74% positive predictive value. Innumerable, different biopsy protocols are regularly proposed, considering clinical/laboratory findings, and findings such as prostate volume and anatomy, among others. In addition to the low prevalence of major complications, there is no doubt that ultrasonography-guided prostate biopsy still plays a significant role in the cancer diagnosis, in spite of its controversial role in the screening for prostate cancer. Despite the routine use of the PSA testing in the study of the prostate, over the last decade PSA levels and random prostate biopsy findings have allowed the diagnosis of some cancers, putting patients through unnecessary treatments for low-degree tumors which would have no consequence if left untreated. On the other hand,

Contribution of transrectal ultrasonography-guided biopsy in the diagnosis of prostate cancer: looking back and ahead